GoAI
Get started
Muromachi Chemicals Inc. logo

Muromachi Chemicals Inc.

4885.T

JPXHealthcareMedical - Pharmaceuticals

Open in GoAI

Latest quote

¥901

+¥1.00 · +0.11%

Aug 24, 10:07 AM JST

4885.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services, including GLP analysis, storage, stability testing, and repurification of radioisotopes. The company also provides traditional tablets; jelly; and non-alcoholic beverage products. In addition, it offers ion-exchange resins; separation membranes; water-treatment products; and contract processing services. Further, it provides functional adhesives; product contamination removal and dust removal mats, and antistatic products for use in the electronics industry; and engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
Headquarters
JP
CEO
Junichi Aoki
Listed since
Feb 26, 2021
Employees
203

Market position

Day range

Current ¥901

52-week range

Current ¥901

Open
¥901
Previous close
¥900
Volume
1K
0.03× average
Average volume
28.99K
Average daily volume
Market cap
3.63B JPY
Beta
0.48
Market reference 1
50-day average
¥908.3
-0.80% below average
200-day average
¥944.87
-4.64% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.19B JPY
EV / EBITDA
4.48×
Earnings yield
4.05%
Free cash flow yield
14.35%

Profitability & efficiency

Return on equity
6.33%
Return on assets
2.57%
Return on invested capital
7.70%

Financial health

Current ratio
2.01×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends33%22%10%-1%Gross margin, FY2021: 30.09%Gross margin, FY2022: 27.37%Gross margin, FY2023: 28.53%Gross margin, FY2024: 28.67%Gross margin, FY2025: 29.30%Operating margin, FY2021: 7.70%Operating margin, FY2022: 5.87%Operating margin, FY2023: 6.62%Operating margin, FY2024: 6.50%Operating margin, FY2025: 9.48%Net margin, FY2021: 8.03%Net margin, FY2022: 4.07%Net margin, FY2023: 5.18%Net margin, FY2024: 3.63%Net margin, FY2025: 2.08%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 30.09%. Gross margin FY2022 27.37%. Gross margin FY2023 28.53%. Gross margin FY2024 28.67%. Gross margin FY2025 29.30%. Operating margin FY2021 7.70%. Operating margin FY2022 5.87%. Operating margin FY2023 6.62%. Operating margin FY2024 6.50%. Operating margin FY2025 9.48%. Net margin FY2021 8.03%. Net margin FY2022 4.07%. Net margin FY2023 5.18%. Net margin FY2024 3.63%. Net margin FY2025 2.08%.

Income trends

Revenue

7.84B JPY+17.86%

Operating income

742.93M JPY+71.90%

Net income

163.03M JPY-32.43%
Income trends across reported periods8.61B JPY5.54B JPY2.47B JPY−604.76M JPYRevenue, FY2021: 5.68B JPYRevenue, FY2022: 6.29B JPYRevenue, FY2023: 6.37B JPYRevenue, FY2024: 6.65B JPYRevenue, FY2025: 7.84B JPYOperating income, FY2021: 437.34M JPYOperating income, FY2022: 369.41M JPYOperating income, FY2023: 421.84M JPYOperating income, FY2024: 432.19M JPYOperating income, FY2025: 742.93M JPYNet income, FY2021: 456.27M JPYNet income, FY2022: 256.3M JPYNet income, FY2023: 330.2M JPYNet income, FY2024: 241.28M JPYNet income, FY2025: 163.03M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 5.68B JPY. Revenue FY2022 6.29B JPY. Revenue FY2023 6.37B JPY. Revenue FY2024 6.65B JPY. Revenue FY2025 7.84B JPY. Operating income FY2021 437.34M JPY. Operating income FY2022 369.41M JPY. Operating income FY2023 421.84M JPY. Operating income FY2024 432.19M JPY. Operating income FY2025 742.93M JPY. Net income FY2021 456.27M JPY. Net income FY2022 256.3M JPY. Net income FY2023 330.2M JPY. Net income FY2024 241.28M JPY. Net income FY2025 163.03M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue7.84B JPY6.65B JPY6.37B JPY6.29B JPY5.68B JPY
Cost of goods sold5.54B JPY4.75B JPY4.55B JPY4.57B JPY3.97B JPY
Gross profit2.3B JPY1.91B JPY1.82B JPY1.72B JPY1.71B JPY
Research and development31.59M JPY25.11M JPY29.27M JPY33.07M JPY29.03M JPY
Selling, general, and administrative1.52B JPY1.45B JPY1.37B JPY1.32B JPY1.24B JPY
Operating expenses1.55B JPY1.47B JPY1.4B JPY1.35B JPY1.27B JPY
Interest income4.83M JPY2.31M JPY2.13M JPY38K JPY4K JPY
Interest expense45.49M JPY29.03M JPY18.46M JPY17.69M JPY17.01M JPY
Depreciation and amortization191.02M JPY161.75M JPY136.19M JPY124.55M JPY105.17M JPY
Operating income742.93M JPY432.19M JPY421.84M JPY369.41M JPY437.34M JPY
Net income163.03M JPY241.28M JPY330.2M JPY256.3M JPY456.27M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
39.99
FY2025 · -32.78% year over year
Latest fiscal-year revenue
7.84B JPY
FY2025 · +17.86% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend119.8290.7961.7632.73FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend8.06B7.19B6.33B5.47BFY21FY22FY23FY24FY25

4885.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

Continue in GoAI

Research 4885.T

research.disclaimer